Phillips Financial Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-463
Closed -$201K 282
2025
Q1
$201K Buy
+463
New +$186K 0.02% 179
2024
Q4
Sell
-499
Closed -$259K 263
2024
Q3
$259K Buy
499
+2
+0.4% +$1.07K 0.02% 162
2024
Q2
$269K Buy
497
+13
+3% +$6.87K 0.02% 156
2024
Q1
$251K Buy
484
+8
+2% +$3.98K 0.02% 160
2023
Q4
$224K Buy
+476
New +$220K 0.02% 160
2023
Q3
Sell
-463
Closed -$206K 240
2023
Q2
$206K Buy
463
+9
+2% +$4.15K 0.02% 157
2023
Q1
$209K Buy
454
+1
+0.2% +$476 0.02% 156
2022
Q4
$232K Buy
453
+11
+2% +$5.58K 0.02% 141
2022
Q3
$201K Buy
+442
New +$211K 0.02% 142
2022
Q2
Sell
-410
Closed -$201K 114
2022
Q1
$201K Buy
+410
New +$187K 0.02% 139

Other funds holding ELV

Phillips Financial Management's ELV Position: Q2 2025 in Review

Phillips Financial Management sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 463 shares — an estimated $201K sold.

Phillips Financial Management first reported a position in ELV in Q1 2022 and held it in 10 quarters. The position peaked at $269K in Q2 2024. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Phillips Financial Management reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Phillips Financial Management sold 463 Elevance Health shares in Q2 2025, an estimated $201K.
  • Phillips Financial Management first reported a position in Elevance Health in Q1 2022 and held it in 10 quarters.
  • Phillips Financial Management's Elevance Health position peaked at $269K in Q2 2024.
  • 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Phillips Financial Management's 13F filing for Q2 2025, filed 30 Jul 2025.